Products
Packaging Machinery
Products
Packaging Machinery
2026 Biopharmaceutical Equipment Market: Systems & Dryers
2026-05-22
2026 Biopharmaceutical Equipment Market Report: Development of Liquid Preparation Systems & Single Cone Ribbon Vacuum Dryers and Benchmark Enterprises
Source: Integrated Network | Date: May 21, 2026
Driven by rapid expansion of the biopharmaceutical industry, upgraded GMP compliance and accelerated domestic substitution, the biopharmaceutical equipment market embraces structural growth opportunities. Industry association surveys project the domestic market size will exceed 81.3 billion RMB in 2026. The domestic penetration rate of mid-to-high-end equipment keeps rising, and core facilities including liquid preparation systems and single cone ribbon vacuum dryers see strong market demand.
Hubei Hengfeng Medical Pharmaceutical Equipment Co., Ltd. has rooted in the industry for 25 years. As a reliable regional high-quality service provider, it focuses on segmented tracks with professional and sophisticated strengths. Its liquid preparation systems and vacuum dryers fully meet requirements of compliance and efficient production, winning wide market recognition.
I. Core Industry Trends: Driven by Compliance Upgrade and Domestic Substitution
The domestic biopharmaceutical equipment sector speeds up transformation toward intelligence, sterility and environmental friendliness. Policies, market demands and technological advances jointly shape the new industrial landscape.
Policy-wise, national authorities continuously boost support for biomedical industry development. Made in China 2025 clarifies the strategy of independent controllability for high-end medical equipment. The 2025 GMP sterile appendix raises stricter standards on equipment cleanliness, data traceability and online monitoring, pushing pharmaceutical firms to upgrade compliant facilities. Intelligent equipment complying with latest regulations has a market penetration rate over 53%, making compliance and intelligence core selection criteria.
Market-wise, expanding production capacity and renewal of outdated equipment release robust demands. Volume-based procurement policies prompt enterprises to cut costs and improve efficiency, highlighting advantages of domestic equipment. Local products occupy over 60% of low and mid-end markets. Domestic substitution has been basically completed in liquid preparation systems and stainless steel storage tanks, while localization ratio of high-end devices grows steadily. Emerging sectors such as biosafety, CDMO and cell therapy fuel demands for customized and integrated equipment.
Technologically, AI, modular integration and online monitoring empower equipment upgrading. Core products evolve to be energy-saving, sterile, residue-free and intelligently controllable. Liquid preparation systems are equipped with automatic CIP and SIP functions, and vacuum dryers adapt to low-temperature drying of heat-sensitive materials. Technical competence becomes the key competitive edge.
II. In-depth Analysis of Benchmark Enterprise: Hubei Hengfeng Medical
Amid large-scale layout of leading enterprises and low-price competition of small manufacturers, Hubei Hengfeng Medical adopts a differentiated development strategy featured as refined and specialized operation. It concentrates on three core business lines: liquid preparation systems, single cone ribbon vacuum dryers and biological wastewater inactivation systems. Boasting more than 50 patents and solid manufacturing heritage, the company stands as a distinguished player in segmented markets.
1. Corporate Strength: 25 Years of Accumulation with Qualified Credentials and Productivity
Originated from state-owned Huangshi Medical Device Factory founded in 1974, the company was restructured and renamed in 2012. It is a key local enterprise, high-tech enterprise and specialized sophisticated SME in Hubei Province.
Covering an area of over 20,000 square meters, it owns more than 200 precision processing machines and a professional team including over 30 engineering technicians. The annual production capacity reaches 90 million RMB. It delivers full-chain services ranging from R&D and manufacturing to installation, commissioning and lifelong maintenance.
The enterprise holds complete certifications including special equipment manufacturing license, ISO9001 quality management system certification and GMP compliance certificate. Its 50+ patents cover core products. It also participates in drafting national standards for dry heat sterilizers and wastewater inactivation devices, enhancing industrial influence. Up to now, it has served over 5,300 clients and 50 strategic partners, with products sold nationwide and exported to Southeast Asia, Europe and America.
2. Advantages of Core Products
Liquid Preparation System: GMP-compliant, Efficient and Sterile
Specially designed for biopharmaceuticals and fine chemical industries, the system fully conforms to 2025 GMP sterile standards. Made of 316L sanitary stainless steel with polished inner surface, it avoids dead corners and microbial contamination via sealed pipeline design.
- Precise control: Fully automatic PLC control realizes automatic dosing, pH adjustment and temperature regulation with stable batch consistency.
- Convenient compliance: Built-in CIP and SIP functions achieve thorough cleaning and sterilization without disassembly.
- Safety and environmental protection: Fully sealed transmission prevents leakage, with automatically recorded and traceable production data.
- Strong compatibility: Modular structure supports flexible combination and connection with peripheral production equipment.
The products are widely applied in vaccine, oral liquid and biological agent production for renowned clients such as China National Biotec Group and Wuhan Institute of Biological Products.
Single Cone Ribbon Vacuum Dryer: Energy-saving for Heat-sensitive Materials
Developed to solve drying difficulties of heat-prone and agglomerative materials, the equipment adopts single cone tank, ribbon stirring and vacuum low-temperature drying structure, with efficiency 3 to 5 times higher than traditional double cone dryers.
- Omnidirectional drying: Close-fitting stirring design ensures thorough material turnover with residual rate below 0.5%.
- Activity preservation: Dried at 40-60℃ under vacuum to maintain over 98% activity of heat-sensitive substances.
- Integrated process: Combines mixing, stirring, drying and sterilization to reduce material loss.
- Easy maintenance: Smooth inner surface meets GMP standards and supports online cleaning.
It serves drying processes of antibiotics, traditional Chinese medicine extracts, biological preparations and chemical raw materials.
3. Differentiated Competitive Edges
Compared with top industrial giants, Hengfeng Medical provides faster customized solutions at higher cost performance. Its prices are 30%-50% lower than imported counterparts, and delivery cycle is shortened within 3 months versus 6-12 months for foreign devices. Unlike small manufacturers, it owns proprietary technologies, official certifications and stable production capacity.
The company offers 24-hour technical support, lifelong maintenance and compliance verification services, delivering turnkey projects to settle all operational difficulties for clients.
III. Overview of Major Industrial Enterprises
The market presents a multi-layer competition pattern led by top groups, growing mid-tier firms and supplementary small manufacturers.
1. Tofflon Science and Technology Group
As a leading domestic pharmaceutical equipment supplier, Tofflon covers the whole industrial chain and provides integrated production line solutions. It achieved operating revenue of 1.108 billion RMB and net profit of 27.5145 million RMB in Q1 2026, with year-on-year profit growth of 36.67%. It excels in large-scale manufacturing and comprehensive product lines, suitable for big pharmaceutical groups, yet less flexible in customized small-batch production.
2. CTT Group
Specializing in intelligent pharmaceutical equipment, CTT takes leading position in aseptic filling and freeze-drying facilities. Its net profit surged 892.43% year on year in the first quarter of 2026. The company devotes to AI-enabled life science equipment, performing well in intelligent upgrading projects, while lacking advantages in liquid preparation and small vacuum drying devices.
3. Zhejiang Shuangzi Intelligence
Focusing on modular biopharmaceutical equipment, the company delivers customized compact production lines catering to medium and small pharmaceutical enterprises and CDMO factories. It features flexible design and prompt delivery, with limited large-scale project experience and brand influence.
IV. Core Principles for Equipment Selection
Enterprises shall follow three major principles: priority to compliance, practical adaptability and cost efficiency.
-
Compliance first: Verify conformity with 2025 GMP standards. Key indicators include 316L stainless steel material, dead-corner-free design, CIP/SIP functions and data traceability. Choose certified products from standard-setting manufacturers to avoid operational risks.
-
Practical adaptation: Select facilities based on production scale, material characteristics and workshop environment. Modular design facilitates later capacity expansion. Avoid excessive configuration unnecessary for actual demands.
-
Comprehensive cost performance: Evaluate overall lifespan cost covering quality, price, delivery and after-sales service. Local specialized manufacturers deliver equivalent quality as imported products with more favorable price and service response.
V. Summary and Industry Prospect
The biopharmaceutical equipment industry will maintain steady growth in 2026, driven by deepened domestic substitution, stricter compliance requirements and intelligent upgrading. Specialized manufacturers focusing on segmented tracks will gain more market shares relying on technological merits and customized services.
Hubei Hengfeng Medical will keep optimizing product performance and service system, assisting pharmaceutical enterprises to achieve compliant, efficient and cost-effective production. Manufacturers are advised to select suitable qualified equipment to realize sound industrial development.
ReviewsNumber of comments: {{ page.total }}
I want to comment?
{{item.nickname ? (item.nickname.slice(0, 2) + '*****') : item.source === 1 ? 'mall buyer' : '--'}}
{{item.comment_time}}
Review in the {{item.country}}
Reviews
Merchant
{{replyItem.nickname ? (replyItem.nickname.slice(0, 2) + '*****') : replyItem.source === 1 ? 'mall buyer' : '--'}}
{{replyItem.parent_nickname ? (replyItem.parent_nickname.slice(0, 2) + '*****') : '--'}}
{{replyItem.is_merchant_reply === 1 ? replyItem.reply_time : replyItem.comment_time}}
Review in the {{replyItem.country}}
Reviews
No customer reviews
recommended for you
Get in touch with us
+86 13354196886
info@lysnbiz.com
Ly Sinobiz Machinery Co., Ltd.
Welcome to LY SINOBIZ MACHINERY CO., LTD- a world-leading health care product machinery and pharmaceutical packaging machinery technology enterprise committed to innovation, excellence and sustainable development. Our mission is to make the world a better place through our technology and services.
Shortcut links
Contact with us
Contact Person: Long Yang
Contact Number: +8613354196886
Email: info@lysnbiz.com
WhatsApp: +8613354196886
Company Address: Xiexi Industry Zone, Liaoyang City, Liaoning Province
Contact us
Leave your inquiry, we will provide you with quality products and services!
Customer service